-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.
-
Summary
-
Barinthus Biotherapeutics plc. quarterly Accounts Receivable, after Allowance for Credit Loss, Current history and change rate from Q4 2020 to Q1 2023.
- Barinthus Biotherapeutics plc. Accounts Receivable, after Allowance for Credit Loss, Current for the quarter ending 31 Mar 2023 was $172K, a 99% decline year-over-year.
Accounts Receivable, after Allowance for Credit Loss, Current, Quarterly (USD)
Accounts Receivable, after Allowance for Credit Loss, Current, YoY Quarterly Change (%)